 | • レポートコード：MRC2-11QY02529 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗凝固剤のグローバル市場について調査・分析したレポートです。種類別（経口、注射可能）市場規模、用途別（DVT、PE、AF）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗凝固剤の競争状況、市場シェア ・世界の抗凝固剤市場：種類別市場規模 2015年-2020年（経口、注射可能） ・世界の抗凝固剤市場：種類別市場規模予測 2021年-2026年（経口、注射可能） ・世界の抗凝固剤市場：用途別市場規模 2015年-2020年（DVT、PE、AF） ・世界の抗凝固剤市場：用途別市場規模予測 2021年-2026年（DVT、PE、AF） ・北米の抗凝固剤市場分析：米国、カナダ ・ヨーロッパの抗凝固剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗凝固剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗凝固剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗凝固剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Boehringer Ingelheim、Bristol-Myers Squibb、Daiichi Sankyo、Pfizer、Johnson & Johnson、Sanofi、AstraZeneca、Eli Lilly、Keryx Biopharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Anticoagulants, commonly referred to as blood thinners, are chemical substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or tablet form, and various intravenous anticoagulant dosage forms are used in hospitals. Some anticoagulants are used in medical equipment, such as test tubes, blood transfusion bags, and dialysis equipment.
The global anticoagulant market is highly competitive due to the presence of several international and regional vendors. The market has observed a high growth because of the increase in usage of NOACs and the growing number of surgeries worldwide. This has influx intense competition among the players in the NOACs market, which is emerging in the anticoagulant market. Also, the growing focus of established vendors in the emerging economies will likely change the market dynamics in the next four years.
Market Analysis and Insights: Global Anticoagulant Market
The global Anticoagulant market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Anticoagulant Scope and Market Size
Anticoagulant market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anticoagulant market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anticoagulant market is segmented into
Oral
Injectable
Segment by Application, the Anticoagulant market is segmented into
DVT
PE
AF
Regional and Country-level Analysis
The Anticoagulant market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anticoagulant market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anticoagulant Market Share Analysis
Anticoagulant market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anticoagulant business, the date to enter into the Anticoagulant market, Anticoagulant product introduction, recent developments, etc.
The major vendors covered:
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Pfizer
Johnson & Johnson
Sanofi
AstraZeneca
Eli Lilly
Keryx Biopharmaceuticals
1 Study Coverage
1.1 Anticoagulant Product Introduction
1.2 Market Segments
1.3 Key Anticoagulant Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Anticoagulant Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Injectable
1.5 Market by Application
1.5.1 Global Anticoagulant Market Size Growth Rate by Application
1.5.2 DVT
1.5.3 PE
1.5.4 AF
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Anticoagulant Market Size, Estimates and Forecasts
2.1.1 Global Anticoagulant Revenue 2015-2026
2.1.2 Global Anticoagulant Sales 2015-2026
2.2 Global Anticoagulant, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Anticoagulant Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Anticoagulant Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anticoagulant Competitor Landscape by Players
3.1 Anticoagulant Sales by Manufacturers
3.1.1 Anticoagulant Sales by Manufacturers (2015-2020)
3.1.2 Anticoagulant Sales Market Share by Manufacturers (2015-2020)
3.2 Anticoagulant Revenue by Manufacturers
3.2.1 Anticoagulant Revenue by Manufacturers (2015-2020)
3.2.2 Anticoagulant Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Anticoagulant Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Anticoagulant Revenue in 2019
3.2.5 Global Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Anticoagulant Price by Manufacturers
3.4 Anticoagulant Manufacturing Base Distribution, Product Types
3.4.1 Anticoagulant Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Anticoagulant Product Type
3.4.3 Date of International Manufacturers Enter into Anticoagulant Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Anticoagulant Market Size by Type (2015-2020)
4.1.1 Global Anticoagulant Sales by Type (2015-2020)
4.1.2 Global Anticoagulant Revenue by Type (2015-2020)
4.1.3 Anticoagulant Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Anticoagulant Market Size Forecast by Type (2021-2026)
4.2.1 Global Anticoagulant Sales Forecast by Type (2021-2026)
4.2.2 Global Anticoagulant Revenue Forecast by Type (2021-2026)
4.2.3 Anticoagulant Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Anticoagulant Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Anticoagulant Market Size by Application (2015-2020)
5.1.1 Global Anticoagulant Sales by Application (2015-2020)
5.1.2 Global Anticoagulant Revenue by Application (2015-2020)
5.1.3 Anticoagulant Price by Application (2015-2020)
5.2 Anticoagulant Market Size Forecast by Application (2021-2026)
5.2.1 Global Anticoagulant Sales Forecast by Application (2021-2026)
5.2.2 Global Anticoagulant Revenue Forecast by Application (2021-2026)
5.2.3 Global Anticoagulant Price Forecast by Application (2021-2026)
6 North America
6.1 North America Anticoagulant by Country
6.1.1 North America Anticoagulant Sales by Country
6.1.2 North America Anticoagulant Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Anticoagulant Market Facts & Figures by Type
6.3 North America Anticoagulant Market Facts & Figures by Application
7 Europe
7.1 Europe Anticoagulant by Country
7.1.1 Europe Anticoagulant Sales by Country
7.1.2 Europe Anticoagulant Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Anticoagulant Market Facts & Figures by Type
7.3 Europe Anticoagulant Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Anticoagulant by Region
8.1.1 Asia Pacific Anticoagulant Sales by Region
8.1.2 Asia Pacific Anticoagulant Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Anticoagulant Market Facts & Figures by Type
8.3 Asia Pacific Anticoagulant Market Facts & Figures by Application
9 Latin America
9.1 Latin America Anticoagulant by Country
9.1.1 Latin America Anticoagulant Sales by Country
9.1.2 Latin America Anticoagulant Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Anticoagulant Market Facts & Figures by Type
9.3 Central & South America Anticoagulant Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Anticoagulant by Country
10.1.1 Middle East and Africa Anticoagulant Sales by Country
10.1.2 Middle East and Africa Anticoagulant Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Anticoagulant Market Facts & Figures by Type
10.3 Middle East and Africa Anticoagulant Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Anticoagulant Products Offered
11.1.5 Bayer Related Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Corporation Information
11.2.2 Boehringer Ingelheim Description and Business Overview
11.2.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Boehringer Ingelheim Anticoagulant Products Offered
11.2.5 Boehringer Ingelheim Related Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Description and Business Overview
11.3.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bristol-Myers Squibb Anticoagulant Products Offered
11.3.5 Bristol-Myers Squibb Related Developments
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Corporation Information
11.4.2 Daiichi Sankyo Description and Business Overview
11.4.3 Daiichi Sankyo Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Daiichi Sankyo Anticoagulant Products Offered
11.4.5 Daiichi Sankyo Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Anticoagulant Products Offered
11.5.5 Pfizer Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Anticoagulant Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description and Business Overview
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Anticoagulant Products Offered
11.7.5 Sanofi Related Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Corporation Information
11.8.2 AstraZeneca Description and Business Overview
11.8.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AstraZeneca Anticoagulant Products Offered
11.8.5 AstraZeneca Related Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Corporation Information
11.9.2 Eli Lilly Description and Business Overview
11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Eli Lilly Anticoagulant Products Offered
11.9.5 Eli Lilly Related Developments
11.10 Keryx Biopharmaceuticals
11.10.1 Keryx Biopharmaceuticals Corporation Information
11.10.2 Keryx Biopharmaceuticals Description and Business Overview
11.10.3 Keryx Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Keryx Biopharmaceuticals Anticoagulant Products Offered
11.10.5 Keryx Biopharmaceuticals Related Developments
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Anticoagulant Products Offered
11.1.5 Bayer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Anticoagulant Market Estimates and Projections by Region
12.1.1 Global Anticoagulant Sales Forecast by Regions 2021-2026
12.1.2 Global Anticoagulant Revenue Forecast by Regions 2021-2026
12.2 North America Anticoagulant Market Size Forecast (2021-2026)
12.2.1 North America: Anticoagulant Sales Forecast (2021-2026)
12.2.2 North America: Anticoagulant Revenue Forecast (2021-2026)
12.2.3 North America: Anticoagulant Market Size Forecast by Country (2021-2026)
12.3 Europe Anticoagulant Market Size Forecast (2021-2026)
12.3.1 Europe: Anticoagulant Sales Forecast (2021-2026)
12.3.2 Europe: Anticoagulant Revenue Forecast (2021-2026)
12.3.3 Europe: Anticoagulant Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Anticoagulant Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Anticoagulant Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Anticoagulant Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Anticoagulant Market Size Forecast by Region (2021-2026)
12.5 Latin America Anticoagulant Market Size Forecast (2021-2026)
12.5.1 Latin America: Anticoagulant Sales Forecast (2021-2026)
12.5.2 Latin America: Anticoagulant Revenue Forecast (2021-2026)
12.5.3 Latin America: Anticoagulant Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Anticoagulant Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Anticoagulant Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Anticoagulant Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Anticoagulant Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Anticoagulant Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Anticoagulant Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Anticoagulant Market Segments
Table 2. Ranking of Global Top Anticoagulant Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Anticoagulant Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Injectable
Table 6. Global Anticoagulant Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Anticoagulant Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Anticoagulant Sales by Regions 2015-2020 (K Units)
Table 9. Global Anticoagulant Sales Market Share by Regions (2015-2020)
Table 10. Global Anticoagulant Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Anticoagulant Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Anticoagulant Sales Share by Manufacturers (2015-2020)
Table 13. Global Anticoagulant Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Anticoagulant by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulant as of 2019)
Table 15. Anticoagulant Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Anticoagulant Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Anticoagulant Price (2015-2020) (USD/Unit)
Table 18. Anticoagulant Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Anticoagulant Product Type
Table 20. Date of International Manufacturers Enter into Anticoagulant Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Anticoagulant Sales by Type (2015-2020) (K Units)
Table 23. Global Anticoagulant Sales Share by Type (2015-2020)
Table 24. Global Anticoagulant Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Anticoagulant Revenue Share by Type (2015-2020)
Table 26. Anticoagulant Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Anticoagulant Sales by Application (2015-2020) (K Units)
Table 28. Global Anticoagulant Sales Share by Application (2015-2020)
Table 29. North America Anticoagulant Sales by Country (2015-2020) (K Units)
Table 30. North America Anticoagulant Sales Market Share by Country (2015-2020)
Table 31. North America Anticoagulant Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Anticoagulant Revenue Market Share by Country (2015-2020)
Table 33. North America Anticoagulant Sales by Type (2015-2020) (K Units)
Table 34. North America Anticoagulant Sales Market Share by Type (2015-2020)
Table 35. North America Anticoagulant Sales by Application (2015-2020) (K Units)
Table 36. North America Anticoagulant Sales Market Share by Application (2015-2020)
Table 37. Europe Anticoagulant Sales by Country (2015-2020) (K Units)
Table 38. Europe Anticoagulant Sales Market Share by Country (2015-2020)
Table 39. Europe Anticoagulant Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Anticoagulant Revenue Market Share by Country (2015-2020)
Table 41. Europe Anticoagulant Sales by Type (2015-2020) (K Units)
Table 42. Europe Anticoagulant Sales Market Share by Type (2015-2020)
Table 43. Europe Anticoagulant Sales by Application (2015-2020) (K Units)
Table 44. Europe Anticoagulant Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Anticoagulant Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Anticoagulant Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Anticoagulant Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Anticoagulant Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Anticoagulant Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Anticoagulant Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Anticoagulant Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Anticoagulant Sales Market Share by Application (2015-2020)
Table 53. Latin America Anticoagulant Sales by Country (2015-2020) (K Units)
Table 54. Latin America Anticoagulant Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Anticoagulant Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Anticoagulant Revenue Market Share by Country (2015-2020)
Table 57. Latin America Anticoagulant Sales by Type (2015-2020) (K Units)
Table 58. Latin America Anticoagulant Sales Market Share by Type (2015-2020)
Table 59. Latin America Anticoagulant Sales by Application (2015-2020) (K Units)
Table 60. Latin America Anticoagulant Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Anticoagulant Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Anticoagulant Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Anticoagulant Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Anticoagulant Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Anticoagulant Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Anticoagulant Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Anticoagulant Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Anticoagulant Sales Market Share by Application (2015-2020)
Table 69. Bayer Corporation Information
Table 70. Bayer Description and Major Businesses
Table 71. Bayer Anticoagulant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Bayer Product
Table 73. Bayer Recent Development
Table 74. Boehringer Ingelheim Corporation Information
Table 75. Boehringer Ingelheim Description and Major Businesses
Table 76. Boehringer Ingelheim Anticoagulant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Boehringer Ingelheim Product
Table 78. Boehringer Ingelheim Recent Development
Table 79. Bristol-Myers Squibb Corporation Information
Table 80. Bristol-Myers Squibb Description and Major Businesses
Table 81. Bristol-Myers Squibb Anticoagulant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Bristol-Myers Squibb Product
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Daiichi Sankyo Corporation Information
Table 85. Daiichi Sankyo Description and Major Businesses
Table 86. Daiichi Sankyo Anticoagulant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Daiichi Sankyo Product
Table 88. Daiichi Sankyo Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Anticoagulant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Johnson & Johnson Corporation Information
Table 95. Johnson & Johnson Description and Major Businesses
Table 96. Johnson & Johnson Anticoagulant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Johnson & Johnson Product
Table 98. Johnson & Johnson Recent Development
Table 99. Sanofi Corporation Information
Table 100. Sanofi Description and Major Businesses
Table 101. Sanofi Anticoagulant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Sanofi Product
Table 103. Sanofi Recent Development
Table 104. AstraZeneca Corporation Information
Table 105. AstraZeneca Description and Major Businesses
Table 106. AstraZeneca Anticoagulant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. AstraZeneca Product
Table 108. AstraZeneca Recent Development
Table 109. Eli Lilly Corporation Information
Table 110. Eli Lilly Description and Major Businesses
Table 111. Eli Lilly Anticoagulant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Eli Lilly Product
Table 113. Eli Lilly Recent Development
Table 114. Keryx Biopharmaceuticals Corporation Information
Table 115. Keryx Biopharmaceuticals Description and Major Businesses
Table 116. Keryx Biopharmaceuticals Anticoagulant Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Keryx Biopharmaceuticals Product
Table 118. Keryx Biopharmaceuticals Recent Development
Table 119. Global Anticoagulant Sales Forecast by Regions (2021-2026) (K Units)
Table 120. Global Anticoagulant Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Anticoagulant Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Anticoagulant Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Anticoagulant Sales Forecast by Country (2021-2026) (K Units)
Table 124. North America: Anticoagulant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Anticoagulant Sales Forecast by Country (2021-2026) (K Units)
Table 126. Europe: Anticoagulant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Anticoagulant Sales Forecast by Region (2021-2026) (K Units)
Table 128. Asia Pacific: Anticoagulant Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Anticoagulant Sales Forecast by Country (2021-2026) (K Units)
Table 130. Latin America: Anticoagulant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Anticoagulant Sales Forecast by Country (2021-2026) (K Units)
Table 132. Middle East and Africa: Anticoagulant Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Anticoagulant Players
Table 137. Anticoagulant Customers List
Table 138. Anticoagulant Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Anticoagulant Product Picture
Figure 2. Global Anticoagulant Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Injectable Product Picture
Figure 5. Global Anticoagulant Sales Market Share by Application in 2020 & 2026
Figure 6. DVT
Figure 7. PE
Figure 8. AF
Figure 9. Anticoagulant Report Years Considered
Figure 10. Global Anticoagulant Market Size 2015-2026 (US$ Million)
Figure 11. Global Anticoagulant Sales 2015-2026 (K Units)
Figure 12. Global Anticoagulant Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Anticoagulant Sales Market Share by Region (2015-2020)
Figure 14. Global Anticoagulant Sales Market Share by Region in 2019
Figure 15. Global Anticoagulant Revenue Market Share by Region (2015-2020)
Figure 16. Global Anticoagulant Revenue Market Share by Region in 2019
Figure 17. Global Anticoagulant Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Anticoagulant Revenue in 2019
Figure 19. Anticoagulant Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Anticoagulant Sales Market Share by Type (2015-2020)
Figure 21. Global Anticoagulant Sales Market Share by Type in 2019
Figure 22. Global Anticoagulant Revenue Market Share by Type (2015-2020)
Figure 23. Global Anticoagulant Revenue Market Share by Type in 2019
Figure 24. Global Anticoagulant Market Share by Price Range (2015-2020)
Figure 25. Global Anticoagulant Sales Market Share by Application (2015-2020)
Figure 26. Global Anticoagulant Sales Market Share by Application in 2019
Figure 27. Global Anticoagulant Revenue Market Share by Application (2015-2020)
Figure 28. Global Anticoagulant Revenue Market Share by Application in 2019
Figure 29. North America Anticoagulant Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Anticoagulant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Anticoagulant Sales Market Share by Country in 2019
Figure 32. North America Anticoagulant Revenue Market Share by Country in 2019
Figure 33. U.S. Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Anticoagulant Market Share by Type in 2019
Figure 38. North America Anticoagulant Market Share by Application in 2019
Figure 39. Europe Anticoagulant Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Anticoagulant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Anticoagulant Sales Market Share by Country in 2019
Figure 42. Europe Anticoagulant Revenue Market Share by Country in 2019
Figure 43. Germany Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Anticoagulant Market Share by Type in 2019
Figure 54. Europe Anticoagulant Market Share by Application in 2019
Figure 55. Asia Pacific Anticoagulant Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Anticoagulant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Anticoagulant Sales Market Share by Region in 2019
Figure 58. Asia Pacific Anticoagulant Revenue Market Share by Region in 2019
Figure 59. China Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Anticoagulant Market Share by Type in 2019
Figure 82. Asia Pacific Anticoagulant Market Share by Application in 2019
Figure 83. Latin America Anticoagulant Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Anticoagulant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Anticoagulant Sales Market Share by Country in 2019
Figure 86. Latin America Anticoagulant Revenue Market Share by Country in 2019
Figure 87. Mexico Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Anticoagulant Market Share by Type in 2019
Figure 94. Latin America Anticoagulant Market Share by Application in 2019
Figure 95. Middle East and Africa Anticoagulant Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Anticoagulant Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Anticoagulant Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Anticoagulant Revenue Market Share by Country in 2019
Figure 99. Turkey Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Anticoagulant Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Anticoagulant Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Anticoagulant Market Share by Type in 2019
Figure 106. Middle East and Africa Anticoagulant Market Share by Application in 2019
Figure 107. North America Anticoagulant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Anticoagulant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Anticoagulant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Anticoagulant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Anticoagulant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Anticoagulant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Anticoagulant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Anticoagulant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Anticoagulant Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Anticoagulant Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
アニシンジオンの世界市場（～2026年） Market Analysis and Insights: Global Anisindione Market The global Anisindione market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anisindione Scope and Market Size Anisindione market is segmented by Type, and by Applicati…- 老年医学の世界市場（～2026年） Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults One of the key factors attributing to its rapid growth include rapidly increasing geriatric population base.…
- 虚血性脳卒中治療薬の世界市場（～2026年） Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. Asia Pacific is anticipated to unfold as the mo…
- 注射可能型ドラッグデリバリーの世界市場（～2026年） Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectables allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body. North Amer…
- 特殊注射用ジェネリック医薬品の世界市場（～2026年） Market Analysis and Insights: Global Specialty Injectable Generics Market The global Specialty Injectable Generics market size is projected to reach US$ 10240 million by 2026, from US$ 9378.7 million in 2020, at a CAGR of 8.4%% during 2021-2026. Global Specialty Injectable Generics Scope and Market …